Mechanisms facilitating timely access to anticipatory medicines for community palliative patients (palliPHARM).

What did we do?

PSA developed mechanisms that facilitate community patients (in private homes residential aged care facilities) to have timely access to symptom control medicines. 

Why did we do it?

To support pharmacists in avoiding unnecessary suffering of patients and unwanted transfers to acute care facilities. 

Value to PSA members

The palliPHARM interventions have raised awareness of palliative care needs amongst the pharmacy sector, improving outcomes for community-based palliative patients.

Project impact

Coming soon.